Skip to main content

Table 2 Contraceptives reported to be associated with tumor growth

From: Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients

Contraceptive (Commercial name) Type Composition Number of patients who experienced tumor growth Number of patients who did not experience tumor growth
Non-Ovlon combined oral 0.05 mg estrogen
1.0 mg noreethisteron acetate
1
slight
7
Marvelon combined oral 0.03 mg estrogen
0.15 mg desogestrel
1
slight
6
Femranette combined oral 0.03 mg estrogen
0.15 mg levonorgestrel
1
slight
1
Trisiston combined oral 0.03 mg estrogen
0.125 mg levonorgestrel
1
slight
1
Ovanon combined oral 0.05 mg estrogen
2.5 mg lynestrenol
1
slight
1
Depot-Clinovir parenteral progestogen 150 mg medroxyprogesterone acetat
200 mg norethisteron enanthat
2
significant
0
\